Regeneron Pharmaceuticals Inc (NASDAQ:REGN) under-valued by 11%
Website | https://www.regeneron.com/ |
Sector | Healthcare |
Industry | Biotechnology |
Fiscal Year End | Dec 31, 2019 |
Market Cap | $61,348,819,000 |
Beta | 0.39922 |
Average Volume | $872,232 |
Last Dividend | 0% |
Price on Aug 5, 2020 | $583.14 |
Autochartist™ Valuation | $644.81 |
Conclusion |
11% under-valued |
Download Report |